Skip to main content

Advertisement

Figure 6 | Nutrition & Metabolism

Figure 6

From: Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics

Figure 6

Fatty acid transcapillary flux in controls and diabetics plus ROSI treatment: Following a standardized mixed meal, TG and NEFA levels were measured and fatty acid transcapillary flux calculated as described in methods for controls and diabetics (A) and diabetics with and without treatment with rosiglitazone (ROSI)(B). Results are expressed as average ± sem with detailed statistics presented in the text.

Back to article page